SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000861177-06-000017
Filing Date
2006-02-14
Accepted
2006-02-14 15:45:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 mylan.txt SC 13G/A 8519
  Complete submission text file 0000861177-06-000017.txt   10710
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Subject) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-10728 | Film No.: 06614504
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE NORTH WACKER DRIVE CHICAGO IL 60606
Business Address ONE NORTH WACKER DRIVE CHICAGO IL 60606
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (Filed by) CIK: 0000861177 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000